Shanghai Kaibao Pharmaceutical Cash Flow Quality Index
Shanghai Kaibao Pharmaceutical cash flow quality index. Shanghai Kaibao Pharmaceutical (300039) has a Cash Flow Quality Index of 2.93x as of September 2025. Operating cash flow of CN¥190.98 Million exceeds net income of CN¥65.09 Million, indicating high earnings quality where cash backs reported profits. See Shanghai Kaibao Pharmaceutical (300039) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shanghai Kaibao Pharmaceutical (2006–2025)
Cash flow quality index of Shanghai Kaibao Pharmaceutical from 2006 to 2025. Historical Cash Flow Quality Index for Shanghai Kaibao Pharmaceutical across 20 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 300039 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Shanghai Kaibao Pharmaceutical Cash Flow Quality Index by Year (2006–2025)
Shanghai Kaibao Pharmaceutical cash flow quality index by year from 2006 to 2025. Year-by-year earnings quality comparison for Shanghai Kaibao Pharmaceutical. For the full cash flow conversion analysis, see 300039 cash flow metrics.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.83x | CN¥230.74 Million | CN¥278.58 Million | ▲ +11.3% |
| 2024 | 0.74x | CN¥278.95 Million | CN¥374.91 Million | ▼ -36.2% |
| 2023 | 1.17x | CN¥382.66 Million | CN¥327.87 Million | ▼ -41.1% |
| 2022 | 1.98x | CN¥376.42 Million | CN¥190.08 Million | ▲ +120.1% |
| 2021 | 0.90x | CN¥126.08 Million | CN¥140.11 Million | ▼ -61.9% |
| 2020 | 2.36x | CN¥250.65 Million | CN¥106.12 Million | ▲ +77.4% |
| 2019 | 1.33x | CN¥334.09 Million | CN¥250.99 Million | ▲ +15.1% |
| 2018 | 1.16x | CN¥262.36 Million | CN¥226.81 Million | ▲ +28.2% |
| 2017 | 0.90x | CN¥245.76 Million | CN¥272.30 Million | ▼ -19.0% |
| 2016 | 1.11x | CN¥314.88 Million | CN¥282.61 Million | ▼ -4.1% |
| 2015 | 1.16x | CN¥327.08 Million | CN¥281.65 Million | ▲ +43.7% |
| 2014 | 0.81x | CN¥282.38 Million | CN¥349.35 Million | ▼ -4.6% |
| 2013 | 0.85x | CN¥270.23 Million | CN¥318.82 Million | ▼ -15.6% |
| 2012 | 1.00x | CN¥243.32 Million | CN¥242.19 Million | ▲ +71.2% |
| 2011 | 0.59x | CN¥98.31 Million | CN¥167.56 Million | ▲ +266.8% |
| 2010 | 0.16x | CN¥19.79 Million | CN¥123.70 Million | ▼ -79.2% |
| 2009 | 0.77x | CN¥52.74 Million | CN¥68.67 Million | ▲ +136.8% |
| 2008 | 0.32x | CN¥18.70 Million | CN¥57.65 Million | ▼ -37.6% |
| 2007 | 0.52x | CN¥23.27 Million | CN¥44.81 Million | ▼ -45.0% |
| 2006 | 0.94x | CN¥19.70 Million | CN¥20.87 Million | — |